MarketCap
Integra LifeSciences Holdings Corporation IART
$ 15.53
2.76%
Facebook
X
Telegram
Integra LifeSciences Holdings Corporation Book Value | IART
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Integra LifeSciences Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 B | 1.55 B | 1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 670 M | 518 M | 493 M | 500 M | 445 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 445 M | 1.05 B |
Quarterly Book Value Integra LifeSciences Holdings Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 B | 1.04 B | 1.04 B | 1.04 B | 1.52 B | 1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | - | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M | 471 M | 460 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 460 M | 1.08 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
129 M | $ 43.32 | 0.04 % | $ 1.99 B |  USA |
 |
Bruker Corporation
BRKR
|
2.51 B | $ 59.67 | 0.18 % | $ 9.06 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
229 M | $ 8.73 | 1.16 % | $ 637 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
28 M | $ 14.97 | 13.03 % | $ 424 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 45.8 | 3.31 % | $ 1.42 B | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 4.91 | 0.75 % | $ 306 M | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 15.96 | 1.8 % | $ 572 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 5.7 | 0.43 % | $ 770 M | USA |
 |
Electromed
ELMD
|
54 M | $ 27.57 | 0.11 % | $ 228 M | USA |
 |
Establishment Labs Holdings
ESTA
|
23.5 M | $ 67.76 | 3.69 % | $ 2.01 B |  Costa-rica |
 |
Edwards Lifesciences Corporation
EW
|
10.3 B | $ 86.82 | 0.51 % | $ 50.8 B | USA |
 |
Align Technology
ALGN
|
4.05 B | $ 148.17 | 4.36 % | $ 10.7 B | USA |
 |
Helius Medical Technologies
HSDT
|
301 M | $ 2.88 | 2.45 % | $ 63.5 M | USA |
 |
Inogen
INGN
|
192 M | $ 5.09 | 2.55 % | $ 135 M | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 69.06 | 0.57 % | $ 2.03 B | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 0.63 | 0.08 % | $ 10.7 M | USA |
 |
IRadimed Corporation
IRMD
|
94.6 M | $ 86.35 | 0.08 % | $ 1.1 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 126.32 | 0.02 % | $ 4.39 B | USA |
|
LENSAR
LNSR
|
-12.2 M | $ 7.15 | 0.14 % | $ 85.5 M | USA |
 |
Medigus Ltd.
MDGS
|
17.6 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Apyx Medical Corporation
APYX
|
14.8 M | $ 2.95 | 1.37 % | $ 121 M | USA |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
50.1 B | $ 89.3 | 0.08 % | $ 114 B | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 4.77 | 0.2 % | $ 705 M | USA |
 |
Accuray Incorporated
ARAY
|
41.7 M | $ 0.23 | 1.0 % | $ 28.2 M | USA |
 |
Myomo
MYO
|
11.4 M | $ 1.64 | 0.3 % | $ 68.6 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
140 M | $ 0.7 | 0.45 % | $ 45.4 M | Israel |
 |
Nemaura Medical
NMRD
|
-11.8 M | - | -17.8 % | $ 2.74 M |  Britain |
 |
InspireMD
NSPR
|
55.2 M | $ 0.74 | 0.16 % | $ 47.6 M | Israel |
 |
Orthofix Medical
OFIX
|
450 M | $ 9.18 | 2.23 % | $ 364 M |  Curacao |
 |
Outset Medical
OM
|
127 M | $ 3.09 | 5.45 % | $ 47 K | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 44.62 | 0.31 % | $ 66.1 B | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 136.49 | 0.01 % | $ 9.6 B | USA |
 |
Profound Medical Corp.
PROF
|
66.4 M | $ 5.74 | 0.16 % | $ 174 M |  Canada |
 |
Quanterix Corporation
QTRX
|
296 M | $ 3.16 | 4.93 % | $ 135 M | USA |
 |
AVITA Medical
RCEL
|
-16.6 M | $ 10.95 | 0.61 % | $ 305 M |  Australia |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
2.93 M | $ 1.78 | 3.98 % | $ 4.94 M | USA |
 |
Smith & Nephew plc
SNN
|
5.29 B | $ 26.82 | 0.07 % | $ 23.3 B | Britain |
 |
Inari Medical
NARI
|
465 M | - | - | $ 4.23 B | USA |
 |
Sensus Healthcare
SRTS
|
48.1 M | $ 3.03 | 0.32 % | $ 49.5 M | USA |
 |
Stryker Corporation
SYK
|
22.4 B | $ 273.4 | 0.38 % | $ 104 B | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 22.43 | 0.55 % | $ 513 M | USA |
 |
TELA Bio
TELA
|
6.31 M | $ 1.3 | 0.71 % | $ 61 M | USA |
 |
Viemed Healthcare
VMD
|
144 M | $ 8.8 | 1.24 % | $ 342 M | USA |
 |
Varex Imaging Corporation
VREX
|
487 M | $ 18.45 | 0.05 % | $ 764 M | USA |
 |
Sientra
SIEN
|
-409 K | - | -16.59 % | $ 10.3 M | USA |